Senior Scientist | 30+ experience | research, academia
Actively Looking for Work
Summary:
A distinguished scientist specializing in cancer immunology and immunotherapy, with over 30 years of experience in academia and research. The scientist holds a PhD in Immunology, has served in senior scientific and academic leadership roles, and has contributed over 100 peer-reviewed articles and several book chapters.
Core Skills & Expertise
- Cancer immunotherapy
- Translational research
- Clinical studies
- Vaccine development
- Oncology research
- Scientific leadership
- Preclinical research
- Cancer immunology
- Academic research
- Scientific editing and peer review
Experience & Achievements:
The scientist served as the Senior Scientist and Director of the Translational Cancer Research Facility at the National Center for Cancer Care and Research in Doha, Qatar. Additionally, the scientist holds academic positions as an Adjunct Associate Professor at the College of Health and Life Sciences, Hamad Bin Khalifa University, and as a Clinical Professor of Biomedical Sciences at the College of Health Sciences, Qatar University. The scientist earned a PhD in Immunology from Salford University, Manchester, UK, in 1992. The professional journey includes significant roles such as leading the Lymphoma-Cancer Vaccine Team at the Paterson Institute for Cancer Research, Christie Hospital, Manchester, UK; serving as a Senior Scientist at King Faisal Specialist Hospital & Research Centre in Riyadh, Saudi Arabia; chairing the Department of Biomedical Research at Dasman Diabetes Institute; and leading the Department of Biomedical Research at King Fahad Specialist Hospital in Dammam, Saudi Arabia. Throughout the career, the scientist has contributed extensively to the field of cancer immunotherapy, focusing on designing and evaluating therapeutic and prophylactic strategies in both preclinical and clinical studies. Research has led to several notable discoveries, including identifying causes of resistance to retinoic acid in acute leukemia, developing novel leukemia vaccines targeting proteinase-3, and demonstrating the potential of lymphoma idiotype as a cancer vaccine target. Furthermore, the scientist was among the first to demonstrate the expression of the PD-L1 inhibitory molecule in breast cancer patients and its role in immune evasion. The scientist has an extensive publication record, with over 100 peer-reviewed articles in high-impact journals, and has contributed to several book chapters. The scientist is also an active editor and reviewer for numerous international scientific journals.
Career Goals:
looking for a senior scientist position with a group leading expertise.